24/06/2005 - Controller General of Patents, Designs, and Trade Marks

_________________________________________________________________
(12) PATENT APPLICATION PUBLICATION
(19) INDIA (21) Application No. 684/CAL/1999 A
(22) Date of filing of Application 04/08/1999 (43) Publication Date: 24/06/2005
(54) Title of the invention: NOVEL N-
BENZYLINDOLE AND BENZOPYRAZOLE
DERIVATIVES WITH ANTI-ASTHMATIC,ANTI-
ALLERGIC,ANTI-INFLAMATORY AND IMMUNE
MODULATING EFFECT”
(51) International classification: C07D 209/22,A61K
31/44
(31) Priority Document No: P4427393.2
(32) Priority Date:03/08/1994
(33) Name of priority country: GERMANY
(86) International Application No and Filing Date: NIL
(87) International Publication No: NIL
(61) Patent of addition to
Application No: NIL
filed on: NIL
(62) Divisional to
Application No: 844/CAL/1995
filed on: 24/07/1995
(57) Abstract:
(71) Name of Applicant: ASTA MEDICA
AKTIENGESELLSCHAFT
Address of the Applicant: AN DER
PIKARDIE 10,D-01277
DRESDEN,GERMANY
(72) Name of the Inventor:
1. LEBAUT GUILLAUME
2. FOUCHARD FABIENNE
3. KUTSCHER BERNHARD
4. EMIG PETER
5. FLEISCHHAUER LLONA
Filed U/S 5(2) before The Patents
(Amendment) Ordinance,2004 : YES
__________________________________________________________________
(12) PATENT APPLICATION PUBLICATION
(19) INDIA (21) Application No. 821/CAL/1999 A
(22) Date of filing of Application 30/09/1999 (43) Publication Date: 24/06/2005
(54) Title of the invention: “HUMANIZED ANTI-FAS
ANTIBODY”
(51) International classification:
Priority Document No: HEI-10-276881
(32) Priority Date: 30/09/1998
(33) Name of priority country: JAPAN
(86) International Application No and Filing Date:
(87) International Publication No:
(61) Patent of addition to
Application No: NIL
filed on: NIL
(62) Divisional to
Application No: NIL
filed on: NIL
(71) Name of Applicant: SANKYO
COMPANY LIMITED
Address of the Applicant: 5-1,NIHONBASHI
HONCHO 3-CHOME,CHUO-KU,TOKYO
103-8426,JAPAN
(72) Name of the Inventor:
1. SERIZAWA NOBUFUSA
2. HARUYAMA HIDEYUKI
3. NAKAHARA KAORI.
4. TAMAKI IKUKO,
5. TAKAHASHI TOHRU
Filed U/S 5(2) before The Patents
(Amendment) Ordinance,2004 : YES
(57) Abstract:
Anti-Fas antibodies are cross-relative with mouse and human Fas and are useful in the treatment of
conditions attributable to abnormalities in the Fas/Fas ligand system.
The Patent Office Journal 24.06.2005 18013